Much of the human enhancement literature focuses on the ethical, social, and political challenges we are likely to face in the future. I will focus instead on whether we can make decisions to modify ourselves that are known to be likely to satisfy our preferences. It seems plausible to suppose that, if a subject is deciding whether to select a reasonably safe and morally unproblematic enhancement, the decision will be an easy one. The subject will simply figure out her preferences (...) and decide accordingly. The problem, however, is that there is substantial evidence that we are not very good at predicting what will satisfy our preferences. This is a general problem that applies to many different types of decisions, but I argue that there are additional complications when it comes to making decisions about enhancing ourselves. These arise not only for people interested in selecting enhancements but also for people who choose to abstain. (shrink)

Despite the promise to boost human potential and wellbeing, enhancement drugs face recurring ethical scrutiny. The present studies examined attitudes toward cognitive enhancement in order to learn more about these ethical concerns, who has them, and the circumstances in which they arise. Fairness-based concerns underlay opposition to competitive use—even though enhancement drugs were described as legal, accessible and affordable. Moral values also influenced how subsequent rewards were causally explained: Opposition to competitive use reduced the causal contribution of the enhanced winner’s (...) skill, particularly among fairness-minded individuals. In a follow-up study, we asked: Would the normalization of enhancement practices alleviate concerns about their unfairness? Indeed, proliferation of competitive cognitive enhancement eradicated fairness-based concerns, and boosted the perceived causal role of the winner’s skill. In contrast, purity-based concerns emerged in both recreational and competitive contexts, and were not assuaged by normalization. (shrink)